A Meta-Analysis of Structural and Functional Brain Imaging in Dementia of the Alzheimer's Type: A Neuroimaging Profile

Neuropsychology Review

Volumn 13, Issue 1, 2003, Pages 1-18

  Zakzanis, Konstantine K ^a,b   Graham, Simon J ^b,c,d   Campbell, Zachariah ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c ROTMAN RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; CT; MRI; Neuroimaging; PET; Review; SPECT

Indexed keywords

ALZHEIMER DISEASE; BRAIN CORTEX; BRAIN FUNCTION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; HIPPOCAMPUS; HUMAN; MEDICAL LITERATURE; MEDICAL RECORD; MEDICAL RESEARCH; META ANALYSIS; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; QUANTITATIVE ANALYSIS; REVIEW; AGED; BRAIN; BRAIN CIRCULATION; COGNITIVE DEFECT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HISTOLOGY; MALE; METABOLISM; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; RADIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULARIZATION;

AGED; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037646287     PISSN: 10407308     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022318921994     Document Type: Review

References (151)

1. *Akiyama, H., Harrop, R., McGeer, P. L., Peppard, R., and McGeer, E. G. (1989). Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease. Neurology 39: 541-548.
2. *Alavi, A., Newberg, A. B., Souder, E., and Berlin, J. A. (1993). Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: Atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J. Nucl. Med. 34: 1681-1687.
3. *Azari, N. P., Pettigrew, K. D., Schapiro, M. B., Haxby, J. V., Grady, C. L., Pietrini, P., et al. (1993). Early detection of Alzheimer's disease: A statistical approach using positron emission tomographic data. J. Cereb. Blood Flow Metab. 13: 438-447.
4. Baron, J. C., Chetelat, G., Desgranges, B., Perchey, G., Landeau, B., de la Sayette, V., et al. (2001). In vivo mapping of gray matter loss with voxel based morphometry in mild Alzheimer's disease. Neuroimage 14: 298-309.
5. *Barta, P. E., Powers, R. E., Aylward, E. H., Chase, G. A., Harris, G. J., Rabins, P. V., et al. (1997). Quantitative MRI volume changes in late onset schizophrenia and Alzheimer's disease compared to normal controls. Psychiatry Res. 68: 65-75.
6. *Bartzokis, G., Sultzer, D., Mintz, J., Holt, L. E., Marx, P., Phelan, C. K., et al. (1994). In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol. Psychiatry 35: 480-487.
7. Beasley, C. M., Nilsson, M. E., Koke, S. C., and Gonzales, J. S. (2000). Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: A meta-analysis of the 20-mg/day dose. J. Clin. Psychiatry 61: 722-728.
8. *Besson, J. A. O., Crawford, J. R., Parker, D. M., and Smith, F. W. (1989). Magnetic resonance imaging in Alzheimer's disease, multi-infarct dementia, alcoholic dementia and Korsakoff's psychosis. Acta Psychiatr. Scand. 80: 451-458.
9. *Biegon, A., Eberling, J. L., Richardson, B. C., Roos, M. S., Wong, S. T. S., Reed, B. R., et al. (1994). Human corpus callosum in aging and Alzheimer's disease: A magnetic resonance imaging study. Neurobiol. Aging 15: 393-397.
10. *Blin, J., Piercey, M., Giuffra, M. E., Mouradian, M. M., and Chase, T. N. (1994). Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography. J. Neurol. Sci. 123: 44-51.
11. Bondi, M. W., and Monsch, A. U. (1998). The role of memory assessment in the preclinical detection of dementia. In: Troster, A. I. (ed.), Memory in Neurodegenerative Disease: Biological, Cognitive, and Clinical Perspectives,Cambridge University Press, Cambridge, MA, pp. 278-289.
12. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82: 239-259.
13. Braak, H., and Braak, E. (1997). Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18: 351-357.
14. Braak, E., Griffing, K., Arai, K., Bohl, J., Bratzke, H., and Braak, H. (1999). Neuropathology of Alzheimer's disease: What is new since A. Alzheimer? Eur. Arch. Psychiatry Clin. Neurosci. 249: S14-S22.
15. 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39: 1423-1427.
16. Buchpiguel, C. A., Alavi, J. B., Alavi, A., and Kenyon, L. C. (1995). PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. J. Nucl. Med. 36: 159-164.
17. *Burns, A., Philpot, M. P., Costa, D. C., and Levy, R. (1989). The investigation of Alzheimer's disease with single photon emission tomography. J. Neurol. Neurosurg. Psychiatry 52: 248-253.
18. *Burns, A., Jacoby, R., Philpot, M., and Levy, R. (1991). Computerised tomography in Alzheimer's disease: Methods of scan analysis, comparison with normal controls, and clinical/radiological associations. Br. J. Psychiatry 159: 609-614.
19. Charletta, D. A., Bennett, D. A., and Wilson, R. S. (1993). Computed tomography and magnetic resonance imaging. In: Parks, R. W., Zec, R. F., and Wilson, R. S. (eds.), Neuropsychology of Alzheimer's Disease and Other Dementias, Oxford University Press, New York, pp. 534-564.
20. *Chawluk, J. B., Dann, R., Alavi, A., Hurtig, H. I., Gur, R. E., Resnick, S., et al. (1990). The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia. Int. J. Radiat. Appl. Instr. 17: 797-804.
21. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd Ed.), Erlbaum,Hillsdale, NJ.
22. Cooper, H. (1979). Statistically combining independent studies: A meta-analysis of sex differences in conformity research. J. Pers. Soc. Psychol. 37: 131-146.
23. Cooper, H., and Hedges, L. V. (1994). The Handbook of Research Synthesis, Russell Sage Foundation, New York.
24. *Costa, D. C., Ell, P. J., Philpot, M., and Levy, R. (1988). CBF tomograms with [99mTc-HM-PAO] in patients with dementia (Alzheimer type and HIV) and Parkinson's disease - Initial results. J. Cereb. Blood Flow Metab. 8: S109-S115.
25. *Cuénod, C.-A., Denys, A., Michot, J.-L., Jehenson, P., Forette, F., Kaplan, D., et al. (1993). Amygdala atrophy in Alzheimer's disease: An in vivo magnetic resonance imaging study. Arch. Neurol. 50: 941-945.
26. Cummings, J. L., and Benson, D. F. (1992). Dementia: A Clinical Approach, Butterworth-Heinemann, Boston.
27. *Currant, S. M., Murray, C. M., Van Beck, M., Dougall, N., O'Carroll, R. E., Austin, M.-P., et al. (1993). A single photon emission computerized tomography study of regional brain function in elderly patients with major depression and with Alzheimer-type dementia. Br. J. Psychiatry 163: 155-165.
28. *Dalgalarrondo, F. H., Riecher-Rössler, A., Geiger-Kabisch, C., and Hentschel, F. (1994). Organic factors and the clinical features of late paranoid psychosis: A comparison with Alzheimer's disease and normal ageing. Acta Psychiatr. Scand. 89: 335-340.
29. Damasio, H., and Damasio, A. R. (1989). Lesion Analysis in Neuropsychology, Oxford University Press, New York.
30. *DeCarli, C., Haxby, J. V., Gillette, J. A., Teichberg, D., Rapoport, S. I., and Schapiro, M. B. (1992). Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology 42: 2029-2036.
31. *DeCarli, C., Murphy, D. G. M., McIntosh, A. R., Teichberg, D., Schapiro, M. B., and Horwitz, B. (1995). Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res. 57: 119-130.
32. *DeCarli, C., Grady, C. L., Clark, C. M., Katz, D. A., Brady, D. R., Murphy, D. G. M., et al. (1996). Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J. Neurol. Neurosurg. Psychiatry 60: 158-167.
33. *De Leon, M. J., George, A. E., Reisberg, B., Kluger, A., Stylopoulos, L. A., Miller, J. D., et al. (1989). Alzheimer's disease: Longitudinal CT studies of ventricular change. Am. J. Roentgenol. 152: 1257-1262.
34. De Leon, M. J., Convit, A., DeSanti, S., Bobinski, M., George, A. E., Wisniewski, H. M., et al. (1997). Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease. Int. Psychogeriatr. 9: 183-190.
35. *Deutsch, G., and Tweedy, J. R. (1987). Cerebral blood flow in severity-matched Alzheimer and multi-infarct patients. Neurology 37: 431-438.
36. *Duara, R., Barker, W. W., Chang, J., Yoshii, F., Loewenstein, D. A., and Pascal, S. (1992). Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease. J. Cereb. Blood Flow Metab. 12: 927-934.
37. *Erkinjuntti, T., Lee, D. H., Gao, F., Steenhuis, R., Eliasziw, M., Fry, R., et al. (1993). Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch. Neurol. 50: 305-310.
38. *Fazekas, F., Alavi, A., Chawluk, J. B., Zimmerman, R. A., Hackney, D., Bilaniuk, L., et al. (1989). Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. J. Nucl. Med. 30: 1607-1615.
39. Folstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). Mini-mental state. J. Psychiatr. Res. 12: 189-198.
40. *Förstl, H., Burns, A., Jacoby, R., Eagger, S., and Levy, R. (1991a). Quantitative CT scan analysis in senile dementia of the Alzheimer type: II. Radioattenuation of grey and white matter. Int. J. Geriatr. Psychiatry 6: 715-719.
41. *Förstl, H., Burns, A., Jacoby, R., Eagger, S., and Levy, R. (1991b). Quantitative CT scan analysis in senile dementia of the Alzheimer type: I. Computerized planimetry of cerebrospinal fluid areas. Int. J. Geriatr. Psychiatry 6: 709-713.
42. Fox, N. C., Crum, W. R., Scahill, R. I., Stevens, J. M., Janssen, J. C., and Rossor, M. N. (2001). Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358: 201-205.
43. *Friedland, R. P., Jagust, W. J., Huesman, R. H., Koss, E., Knittel, B., Mathis, C. A., et al. (1989). Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology 39: 1427-1434.
44. *Frisoni, G. B., Beltramello, A., Geroldi, C., Weiss, C., Bianchetti, A., and Trabucchi, M. (1996). Brain atrophy in frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 61: 157-165.
45. *Frisoni, G. B., Laakso, M. P., Beltramello, A., Geroldi, C., Bianchetti, A., Soininen, H., et al. (1999). Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52: 91-100.
46. *Fukuyama, H., Ogawa, M., Yamauchi, H., Yamaguchi, S., Kimura, J., Yenokura, Y., et al. (1994). Altered cerebral energy metabolism in Alzheimer's disease: A PET study. J. Nucl. Med. 35: 1-6.
47. Gloaguen, V., Cottraux, J., Cucherat, M., and Blackburn, I. M. (1998). A meta-analysis of the effects of cognitive therapy in depressed patients. J. Affect. Disord. 49: 59-72.
48. *Goto, I., Taniwaki, T., Hosokawa, S., Otsuka, M., Ichiya, Y., and Ichimiya, A. (1993). Positron emission tomographic (PET) studies in dementia. J. Neurol. Sci. 114: 1-6.
49. Gould, R. A., Mueser, K. T., Bolton, E., Mays, V., and Goff, D. (2001). Cognitive therapy for psychosis in schizophrenia: An effect size analysis. Schizophr. Res. 48: 335-342.
50. Grady, C. L., and Craik, F. I. (2000). Changes in memory processing with age. Curr. Opin. Neurobiol. 10: 224-231.
51. *Grady, C. L., Haxby, J. V., Horwitz, B., Gillette, J., Salerno, J. A., Gonzalez-Aviles, A., et al. (1993). Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol. Aging 14: 35-44.
52. *Greene, J. D. W., Miles, K., and Hodges, J. R. (1996). Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type. J. Neurol. 243: 175-190.
53. *Grandman, M., Corey-Bloom, J., Jernigan, T., Archibald, S., and Thal, L. J. (1996). Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology 46: 1585-1591.
54. *Guze, B. H., Hofman, J. M., Maziotta, J. C., Baxter, L. R., Jr., and Phelps, M. E. (1992). Positron emission tomography and familial Alzheimer's disease: A pilot study. J. Am. Geriatr. Soc. 40: 120-123.
55. *Hampel, H., Teipel, S. J., Alexander, G. E., Horwitz, B., Teichberg, D., Schapiro, M. B., et al. (1998). Corpus callosum atrophy is a possible indicator of region-and cell type-specific neuronal degeneration in Alzheimer disease. Arch. Neurol. 55: 193-198.
56. *Harris, G. J., Lewis, R. F., Satlin, A., English, C. D., Scott, T. M., Yurgelun-Todd, D. A., et al. (1996). Dynamic susceptibility contrast MRI of regional blood volume in Alzheimer's disease. Am. J. Psychiatry 153: 721-724.
57. *Haxby, J. V., Grady, C. L., Koss, E., Horwitz, B., Schapiro, M., Friedland, R. P., et al. (1988). Heterogenous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 38: 1853-1863.
58. *Haxby, J. V., Grady, C. L., Koss, E., Horwitz, B., Heston, L., Schapiro, M., et al. (1990). Longitudinal study of cerebral metabolic asymetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch. Neurol. 47: 753-760.
59. Hedges, L. V., and Olkin, I. (1985). Statistical Methods for Meta-Analysis, Academic Press, New York.
60. *Hellman, R. S., Tikofsky, R. S., Collier, B. D., Hoffmann, R. G., Palmer, D. W., Glatt, S. L., et al. (1989). Alzheimer disease: Quantitative analysis of I-123-iodoamphetamine SPECT brain imaging. Radiology 172: 183-188.
61. Honig, L. S., and Mayeux, R. (2001). Natural history of Alzheimer's disease. Aging 13: 171-182.
62. Hunter, J. E., and Schmidt, F. L. (1990). Methods of Meta-Analysis, Sage, Newbury Park, CA.
63. *Ishii, K., Imamura, T., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H., et al. (1998). Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 51: 125-130.
64. Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., et al. (1997). Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 49: 786-794.
65. *Jack, C. R., Jr., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., et al. (1998). Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 51: 993-999.
66. Jagust, W. J., Johnson, K. A., and Holman, B. L. (1995). SPECT perfusion imaging in the diagnosis of dementia. J. Neuroimaging 5: S45-S52.
67. *Johnson, K. A., Homan, B. L., Mueller, S. P., Rosen, T. J., English, R., Nagel, J. S., et al. (1988). Single photon emission computed tomography in Alzheimer's disease: Abnormal iofetamine I 123 uptake reflects dementia severity. Arch. Neurol. 45: 392-396.
68. *Johnson, K. A., Holman, L., Rosen, T. J., Nagel, J. S., English, R. J., and Growdon, J. H. (1990). Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch. Intern. Med. 150: 752-756.
69. *Juottonen, K., Laakso, M. P., Partanen, K., and Soininen, H. (1999). Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. Am. J. Neuroradiol. 20: 139-144.
70. 99mTc-HMPAO SPECT. Neuroradiology 36: 1-6.
71. *Kawabata, K., Tachibana, H., Sugita, M., and Fukuchi, M. (1993). A comparative I-123 SPECT study in Binswanger's disease and Alzheimer's disease. Clin. Nucl. Med. 18: 329-336.
72. *Kido, D. K., Caine, E. D., LeMay, M., Ekholm, S., Booth, H., and Panzer, R. (1989). Temporal lobe atrophy in patients with Alzheimer disease: A CT study. Am. J. Neuroradiol. 10: 551-555.
73. *Kidron, D., Black, S. E., Stanchev, P., Buck, B., Szalai, J. P., Parker, J., et al. (1997). Quantitative MR volumetry in Alzheimer's disease: Topographic markers and the effects of sex and education. Neurology 49: 1504-1512.
74. *Killiany, R. J., Moss, M. B., Albert, M. S., Sandor, T., Tieman, J., and Jolesz, F. (1993). Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch. Neurol. 50: 949-954.
75. 11C] aminocyclohexanecarboxylate for the measurement of amino acid uptake and distribution volume in human brain. J. Cereb. Blood Flow Metab. 10: 727-739.
76. *Krasuski, J. S., Alexander, G. E., Horwitz, B., Daly, E. M., Murphy, D. G. M., Rapoport, S. I., et al. (1998). Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol. Psychiatry 43: 60-68.
77. *Kumar, A., Schapiro, M. B., Grady, C., Haxby, J. V., Wagner, E., Salerno, J. A., et al. (1991). High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 4: 35-46.
78. *Kuwabara, Y., Ichiya, Y., Otsuka, M., Masuda, K., Ichimiya, A., and Fujishima, M. (1992). Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type. Stroke 23: 594-598.
79. *Laakso, M. P., Partanen, K., Riekkinen, P., Jr., Lehtovirta, M., Helkala, E.-L., Hallikainen, M., et al. (1996). Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46: 678-681.
80. Lachner, G., and Engel, R. R. (1994). Differentiation of dementia and depression by memory tests. A meta-analysis. J. Nerv. Ment. Dis. 182: 34-39.
81. *Lehéricy, S., Baulac, M., Chiras, J., Piérot, L., Martin, N., Pillon, B., et al. (1994). Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. Am. J. Neuroradiol. 15: 927-937.
82. *Lehtovirta, M., Soininen, H., Laakso, M. P., Partanen, K., Helisalmi, S., Mannermaa, A., et al. (1996). SPECT and MRI analysis in Alzheimer's disease: Relation to apolipoprotein E 4 allele. J. Neurol. Neurosurg. Psychiatry 60: 644-649.
83. *Lehtovitra, M., Kuikka, J., Helisalmi, S., Hartikainen, P., Mannermaa, A., Ryynänen, M., et al. (1998). Longitudinal SPECT study in Alzheimer's disease: Relation to apolipoprotein E polymorphism. J. Neurol. Neurosurg. Psychiatry 64: 742-746.
84. Lipsey, M. W., and Wilson, D. B. (1993). The efficacy of psychological, educational, and behavioral treatment. Am. Psychol. 12: 1181-1209.
85. *Loewenstein, D. A., Barker, W. W., Chang, J.-Y., Apicella, A., Yoshii, F., Kothari, P., et al. (1989). Predominant left hemispere metabolic dysfunction in dementia. Arch. Neurol. 46: 146-152.
86. *Luxenberg, J. S., Haxby, J. V., Creasey, H., Sundaram, M., and Rapoport, S. I. (1987). Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Neurology 37: 1135-1140.
87. *Lyoo, I. K., Satlin, A., Lee, C. K., and Renshaw, P. F. (1997). Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia. Psychiatry Res. 74: 63-72.
88. Matsuda, H. (2001). Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann. Nucl. Med. 15: 85-92.
89. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlin, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
90. Mega, M. S., Thompson, P. M., Toga, A. W., and Cummings, J. L. (2000). Brain mapping in dementia. In: Mazziotta, J. C., Toga, A. W., and Frackowiak, R. S. J. (eds.), Brain Mapping: The Disorders, Academic Press, San Diego, CA, pp. 218-248.
91. *Meltzer, C. C., Zubieta, J. K., Brandt, J., Tune, L. E., Mayberg, H. S., and Frost, J. J. (1996). Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 47: 454-461.
92. Mentis, M. J. (2000). Positron emission tomography and single photon emission computed tomography imaging in Alzheimer's disease. Neurologist 6: 28-43.
93. *Mentis, M. J., Weinstein, E. A., Horwitz, B., McIntosh, A. R., Pietrini, P., Alexander, G. E., et al. (1995). Abnormal brain glucose metabolism in the delusional misidentification syndromes: A positron emission tomography study in Alzheimer disease. Biol. Psychiatry 38: 438-449.
94. *Mentis, M. J., Horwitz, B., Grady, C. L., Alexander, G. E., VanMeter, J. W., Maisog, J. M., et al. (1996). Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am. J. Psychiatry 153: 32-40.
95. *Messa, C., Perani, D., Lucignani, G., Zerorini, A., Zito, F., Rizzo, G., et al. (1994). High-resolution technetium-99m-HMPAO SPECT in patients with probably Alzheimer's disease: Comparison with fluorine-18-FDG PET. J. Nucl. Med. 35: 210-216.
96. *Meyer, M., Koeppe, R. A., Frey, K. A., Foster, N. L., and Kuhl, D. E. (1995). Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch. Neurol. 52: 314-317.
97. *Mielke, R., Herholz, K., Grond, M., Kessler, J., and Heiss, W.-D. (1991). Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol. Aging 13: 93-98.
98. *Mielke, R., Pietrzyk, U., Jacobs, A., Fink, G. R., Ichimiya, A., Kessler, J., et al. (1994). HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: Comparison of perfusion and metabolic pattern. Eur. J. Nucl. Med. 21: 1052-1060.
99. *Mori, E., Yoneda, Y., Yamashita, H., Hirono, N., Ikeda, M., and Yamadori, A. (1997). Medial temporal structures relate to memory impairment in Alzheimer's disease: An MRI volumetric study. J. Neurol. Neurosurg. Psychiatry 63: 214-221.
100. *Murphy, D. G. M., DeCarli, C. D., Daly, E., Gillette, J. A., McIntosh, A. R., Haxby, J. V., et al. (1993). Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: Correlations with disease severity. Biol. Psychiatry 34: 612-621.
101. *Obara, K., Meyer, J. S., Mortel, K. F., and Muramatsu, K. (1994). Cognitive declines correlate with decreased cortical volume and perfusion in dementia of Alzheimer type. J. Neurol. Sci. 127: 96-102.
102. *O'Mahony, D., Coffey, J., Murphy, J., O'Hare, N., Hamilton, D., Freyne, P., et al. (1994). The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J. Nucl. Med. 35: 1450-1455.
103. Orwin, R. G. (1983). A fail safe N for effect size. J. Educ. Stat. 8: 157-159.
104. *Pálsson, S., Aevarsson, O., and Skoog, I. (1999). Depression, cerebral atrophy, cognitive performance and incidence of dementia: Population study of 85-year-olds. Br. J. Psychiatry 174: 249-253.
105. *Pantel, J., Schröder, J., Essig, M., Popp, D., Dech, H., Knopp, M. V., et al. (1997). Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J. Affect. Disord. 42: 69-83.
106. *Parsey, R. V., and Krishnan, K. R. R. (1998). Quantitative analysis of T2 signal intensities in Alzheimer's disease. Psychiatry Res. Neuroimaging 82: 181-185.
107. *Pearlson, G. D., Rabins, P. V., Kim, W. S., Speedie, L. J., Moberg, P. J., Burns, A., et al. (1989). Structural brain CT changes and cognitive deficits in elderly depressives with and without reversible dementia ('pseudodementia'). Psychol. Med. 19: 573-584.
108. *Pearlson, G. D., Harris, G. J., Powers, R. E., Barta, P. E., Camargo, E. E., Chase, G. A., et al. (1992). Quantitative changes in mesial temporal volume regional cerebral blood flow, and cognition in Alzheimer's disease. Arch. Gen. Psychiatry 49: 402-408.
109. *Pfefferbaum, A., Sullivan, E. V., Jernigan, T. L., Zipursky, R. B., Rosenbloom, M. J., Yesavage, J. A., et al. (1990). A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's disease. Psychiatry Res. 35: 115-136.
110. *Pietrini, P., Furey, M. L., Graff-Radford, N., Freo, U., Alexander, G. E., Grady, C. L., et al. (1996). Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: Clinical implications. Am. J. Psychiatry 153: 1261-1268.
111. 2 relaxation time in temporal lobe epilepsy but not in Alzheimer's disease. Neurology 46: 1724-1730.
112. *Prohovnik, I., Mayeux, R., Sackeim, H. A., Smith, G., Stern, Y., and Alderson, P. O. (1988). Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology 38: 931-937.
113. *Riddle, W., O'Carroll, R. E., Dougall, N., Van Beck, M., Murray, C., Curran, S. M., et al. (1993). A single photon emission computerised tomography study of regional brain function underlying verbal memory in patients with Alzheimer-type dementia. Br. J. Psychiatry 163: 166-172.
114. *Rinne, J. O., Sahlberg, N., Ruottinen, H., Någren, K., and Lehikoinen, P. (1998). Striatal uptake of the dopamine reuptake ligand [11C] -CFT is reduced in Alzheimer's disease assessed by positron emission tomography. Neurology 1998: 152-156.
115. Rosenthal, R. (1991). Meta-Analytic Procedures for Social Research, Sage, Beverly Hills, CA.
116. Rosenthal, R. (1995). Writing meta-analytic reviews. Psychol. Bull. 118: 183-192.
117. Russo, R., and Spinnler, H. (1994). Implicit verbal memory in Alzheimer's disease. Cortex 30: 359-375.
118. *Salat, D. H., Kaye, J. A., and Janowsky, J. S. (1999). Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. Arch. Neurol. 56: 338-344.
119. *Sandor, T., Albert, M., Stafford, J., and Harpley, S. (1988). Use of computerized CT analysis to discriminate between Alzheimer patients and normal control subjects. Am. J. Neuroradiol. 9: 1181-1187.
120. *Sandor, T., Jolesz, F., Tieman, J., Kikinis, R., Jones, K., and Albert, M. (1992). Comparative analysis of computed tomography and magnetic resonance imaging scans in Alzheimer patients and controls. Arch. Neurol. 49: 381-384.
121. Sawle, G. V. (1995). Imaging the head: Functional imaging. J. Neurol. Neurosurg. Psychiatry 58: 132-144.
122. *Schapiro, M. B., Pietrini, P., Grady, C. L., Ball, M. J., DeCarli, C., Kumar, A., et al. (1993). Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 56: 859-864.
123. *Schwartz, J. M., Aylward, E., Barta, P. E., Tune, L. E., and Pearlson, G. D. (1992). Sylvian fissure size in schizophrenia measured with magnetic resonance imaging rating protocol of the consortium to establish a registry for Alzheimer's disease. Am. J. Psychiatry 149: 1195-1198.
124. Scinto, L. F. M., and Daffner, K. R. (2000). Early Diagnosis of Alzheimer's Disease, Humana Press, Totowa, NJ.
125. *Shear, P. K., Sullivan, E. V., Mathalon, D. H., Lim, K. O., Davis, L. F., Yesavage, J. A., et al. (1995). Longitudinal volumetric computed tomographic analysis of regional changes in normal aging and Alzheimer's disease. Arch. Neurol. 52: 392-402.
126. *Smith, G. S., de Leon, M. J., George, A. E., Kluger, A., Volkow, N. D., McRae, T., et al. (1992). Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease: Pathophysiologic implications. Arch. Neurol. 49: 1142-1150.
127. 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease. J. Neural Transm. 9: 95-109.
128. *Spampinato, U., Habert, M. O., Mas, J. L., Bourdel, M. C., Ziegler, M., de Recondo, J., et al. (1991). (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: A comparison with dementia of the Alzheimer type. J. Neurol. Neurosurg. Psychiatry 54: 787-792.
129. Sperling, R. A., Sandson, T. A., and Johnson, K. A. (2000). Functional imaging in Alzheimer's disease. In: Scinto, L. F. M., and Daffner, K. R. (eds.), Early Diagnosis of Alzheimer's Disease, Humana Press, Totowa, NJ, pp. 149-168.
130. *Starkstein, S. E., Migliorelli, R., Tesón, A., Sabe, L, Vázquez, S., Turjanski, M., et al. (1994). Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J. Neurol. Neurosurg. Psychiatry 57: 790-795.
131. Stern, Y. (2002). What is cognitive reserve? Theory and research application of the reserve concept. J. Int. Neuropsychol. Soc. 8: 448-460.
132. 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type - A study under clinical routine conditions. J. Neural Transm. 99: 195-221.
133. *Sullivan, E. V., Shear, P. K., Mathalon, D. H., Kelvin, O. L., Yesavage, J. A., Tinklenberg, J. R., et al. (1993). Greater abnormalities of brain cerebrospinal fluid volumes in younger than in older patients with Alzheimer's disease. Arch. Neurol. 50: 359-373.
134. *Szelies, B., Grond, M., Herholz, K., Kessler, J., Wullen, T., and Heiss, W.-D. (1992). Quantitative EEG mapping and PET in Alzheimer's disease. J. Neurol. Sci. 110: 46-56.
135. *Szelies, B., Mielke, R., Herholz, K., and Heiss, W.-D. (1994). Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia. Electroencephalogr. Clin. Neurophysiol. 91: 131-139.
136. *Talbot, P. R., Lloyd, J. J., Snowden, J. S., Neary, D., and Testa, H. J. (1993). Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur. J. Nucl. Med. 21: 503-508.
137. *Tamminga, C. A., Foster, N. L., Fedio, P., Bird, E. D., and Chase, T. N. (1987). Alzheimer's disease: Low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism. Neurology 37: 161-165.
138. *Teipel, S. J., Hampel, H., Alexander, G. E., Schapiro, M. B., Horwitz, B., Teichberg, D., et al. (1998). Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease. Neurology 51: 1381-1385.
139. *Tyrrell, P. J., Sawle, G. V., Ibanez, V., Bloomfield, P. M., Leenders, K. L., Frackowiak, R. S., et al. (1990). Clinical and positron emission tomographic studies in the extrapyramidal syndrome of dementia of the Alzheimer type. Arch. Neurol. 47: 1318-1323.
140. *Van Dyck, C. H., Lin, C. H., Robinson, R., Cellar, J., Smith, E. O., Nelson, J. C., et al. (1997). The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease. Psychopharmacology (Berl.) 132: 217-226.
141. Van Horn, J. D., and McManus, I. C. (1992). Ventricular enlargement in schizophrenia: A meta-analysis of studies of the ventricle:brain ratio (VBR). Br. J. Psychiatry 160: 687-697.
142. *Vermersch, P., Schelten, P., Barkhof, F., Steinling, M., and Leys, D. (1993). Evidence for atrophy of the corpus callosum in Alzheimer's disease. Eur. J. Neurol. 34: 83-86.
143. Wagner, H. N., Jr., and Conti, P. S. (1991). Advances in medical imaging for cancer diagnosis and treatment. Cancer 67: 1121-1128.
144. *Wahlund, L.-O., Andersson-Lundman, G., Basun, H., Almkvist, O., Björkstén, K. S., Sääf, J., et al. (1993). Cognitive functions and brain structures: A quantitative study of CSF volumes on Alzheimer patients and healthy control subjects. Magn. Reson. Imaging 11: 169-174.
145. *Waldemar, G., Brunh, P., Kristensen, M, Johnsen, A., Paulson, O. B., and Lassen, N. A. (1994). Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: A [99mTc]-d, 1-HMPAO SPECT study. J. Neurol. Neurosurg. Psychiatry 57: 285-295.
146. Wolf, F. M. (1986). Meta-Analysis: Quantitative Methods for Research Synthesis, Sage, Newbury Park, CA.
147. *Yamauchi, H., Fukuyama, H., Harada, K., Nabatame, H., Ogawa, M., Ouchi, Y., et al. (1993). Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. Arch. Neurol. 50: 1070-1074.
148. Zakzanis, K. K. (1998a). Brain is related to behavior (p < .05). J. Clin. Exp. Neuropsychol. 20: 419-427.
149. Zakzanis, K. K. (1998b). Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type. J. Clin. Exp. Neuropsychol. 20: 259-269.
150. Zakzanis, K. K. (2001). Statistics to tell the truth, the whole truth, and nothing but the truth: Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Arch. Clin. Neuropsychol. 16: 653-667.
151. Zakzanis, K. K., Leach, L., and Kaplan, E. (1999). Neuropsychological Differential Diagnosis, Swets and Zeitlinger, Lisse, The Netherlands.